2070.SR
2070.SR
SA0007879188
Saudi Pharmaceutical Industries
Loading chart...

Company Profile

Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco. The company operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains a secondary care hospital. In addition, it manufactures human medicines, and wholesales and retails of medicines and related products. Further, the company engages in the research and development of medical science activities, and investment business in related industries. The company was incorporated in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.

Related stocks

4016.SR
4016.SR • Saudi Arabia
Middle East Pharmaceutical Indu
63.25 SAR
589.55M USD 1Y -17.4%
2230.SR
2230.SR • Saudi Arabia
Saudi Chemical Co.
7.22 SAR
1.62B USD 1Y +0.6%
4015.SR
4015.SR • Saudi Arabia
Jamjoom Pharmaceuticals Factory
128 SAR
2.39B USD 1Y -19.2%
ECILC.IS
ECILC.IS • Türkiye
ECZACIBASI ILAC
62.3 TRY
866.66M USD 1Y -32%
APN.JO
APN.JO • South Africa
Aspen Pharmacare Hldgs Ltd
15,826 ZAc
4.15B USD 1Y +65.2%
600557.SS
600557.SS • China
JIANGSU KANION PHARMACEUTICAL C
12.4 CNY
1.05B USD 1Y -18.4%
STAR.NS
STAR.NS • India
STRIDES PHARMA SCI LTD
1,085.3 INR
1.03B USD 1Y +37.4%
2005.HK
2005.HK • Hong Kong SAR China
SSY GROUP
2.67 HKD
975.57M USD 1Y -10.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
34.1% p.a.
Max Drawdown (5Y)
-51.7%
Sharpe Ratio (5Y)
-0.28
Beta Factor
0.39
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -64.6% in the extended horizon.
ende